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Abstract.  Prior studies have given no evidence for 
regulation of vitamin D  receptor (VDR) compartmen- 
talization or subcellular organization. Microwave fixa- 
tion (9-15 s) and an indirect immunodetection system 
of avidin-biotin enhancement and phycoerythrin fluoro- 
phore resulted in sufficient spatial and temporal reso- 
lution to allow analysis of these processes. We studied 
cultured fibroblasts from normals or from patients 
with four different types of hereditary defect com- 
promising VDR function (mutant cells). 
Compartmentalization of VDRs in the absence of 
1,25-dihydroxyvitamin D3 (calcitriol) was regulated by 
serum or estrogen. VDRs were mainly cytoplasmic in 
cells cultured without serum and phenol red, but 
VDRs were mainly intranuclear after addition of se- 
rum or an estrogen to cells for at least 18 h (slow 
regulation). 
Calcitriol initiated a rapid and multistep process 
(rapid regulation) of reorganization in a portion of 
VDRs: clumping within 15-45 s, alignment of clumps 
along fibrils within 30-45 s, perinuclear accumulation 
of clumps within 45-90 s, and intranuclear accumula- 
tion of clumps within 1-3 roan. We found similar 
rapid effects of calcitriol on VDRs in various other 
types of cultured cells. These sequential VDR pattern 
changes showed calcitriol dose dependency and cal- 
citriol analogue specificity characteristic for the VDR. 
In mutant fibroblasts VDR pattern changes after cal- 
citriol were absent or severely disturbed at selected 
steps.  Treatment of normal cells with wheat germ ag- 
glutinin, which blocks protein transport through nu- 
clear pores, also blocked calcitriol-dependent translo- 
cation of VDRs. 
We conclude that immunocytology after microwave 
fixation provides evidence for regulation of VDR orga- 
nization and localization. 
H 
ORMONE binding to the vitamin D receptor (VDR) ~ 
and other steroid receptor-related proteins  initiates 
a process of receptor activation that allows the recep- 
tor to become competent to regulate transcription  (7, 27). 
Steroid-related receptors may also mediate certain rapid (so- 
called nongenomic) effects of their hormonal agonists (4, 17, 
34,  68,  70).  Initiation  of these genomic and nongenomic 
effects  may be  similar  among  steroid-related  receptors, 
through biochemical and physical changes in the receptors, 
such as changes in phosphorylation  (46, 52) and/or changes 
in binding to other cell components (i.e., identical proteins 
or other proteins [8, 22,  36]). 
Despite  many studies,  there is  controversy  concerning 
receptor  compartmentalization  and  possible  subcellular 
changes in receptor distribution  patterns after binding be- 
tween a steroid hormone and its receptor (44, 73). Studies 
of steroid-related  receptors in the 1960s and 1970s, prin- 
1. Abbreviations  used in this paper: VDR, vitamin D receptor; WGA, wheat 
germ agglutirtin. 
cipally with radioactive hormones, suggested that unstimu- 
lated  receptors  were  mainly  in  the  cytoplasm.  Parallel 
studies  suggested  that  steroid  hormone binding  initiated 
receptor translocation  into the nucleus within minutes (76) 
or,  in most studies,  later than 0.5-4 h after hormone ex- 
posure (73).  Subsequently, immunocytology and cell frac- 
tionation suggested that even nonactivated steroid receptors 
are predominantly intranuclear,  and the evidence for recep- 
tor translocation was widely criticized as an artifact (20, 21, 
33, 24, 44, 73). However, further evidence has accumulated 
recently that the hormone-free glucocorticoid receptor,  in 
particular, resides in the cytoplasm, c0mplexed to the 90-kD 
heat shock protein (hsp90) (56) and translocates into the nu- 
cleus after agonist binding (1, 25, 61, 64). 
Methodologic  limitations  (antigen  diffusion  or modifi- 
cation during fixation, poor specimen permeability to anti- 
bodies, loss of antigen during tissue permeabilization,  poor 
spatial resolution, poor temporal resolution, suboptimal anti- 
body affinity or specificity, and other causes for inadequate 
signal to noise ratios) may have precluded visualization of 
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minutes of the receptor activation process.  Recent develop- 
ments such as microwave energy fixation of tissues  (5, 37, 
42),  high  efficiency  immunodetection  systems  (23),  and 
computer-aided image analysis and enhancement (31) sug- 
gested the possibility of sufficient temporal and spatial reso- 
lution to allow evaluation of compartmentalization and orga- 
nization of VDRs and the rapid effects of agonist binding. 
VDRs may be better suited for this evaluation than some 
other steroid-related receptors (29) because VDRs seem to 
be synthesized as a single species of protein (27; Pike, J. W., 
unpublished data; DeLuca, H. E, unpublished data). 
Materials and Methods 
Reagents 
Ia,25-(OH)2D3  was from M. Usknkovic (Hoffman-LaRoche,  Nutley, NJ); 
I~,25-(OH)2D3  was from M.  Holick and Rahul Ray (Boston University 
Medical School, Boston, MA). Immunocytolngy reagents were from Vec- 
tor Laboratories, Inc. (Burlingame,  CA), Sigma Chemical Co. (St. Louis, 
MO), and Zymed Lab. Inc. (San Francisco, CA). Rat monoclonal antibody 
(9A7) against chicken VDR was previously  described (45,  57);  mouse 
monoclomd antibodies (IVGSC11 and VD2F12) against porcine VDR were 
also described previously (16, 56). Cholecalci-ferol,  17~-estradiol,  17a- 
estradiol, diethylstilbestrol, androstenediol, and progesterone were from 
Sigma Chemical Co. Wheat germ agglutinin (WGA) was from Vector Lab- 
oratories, Inc. 
Cell Sources 
Normal dermal fibroblasts were from three subjects (6). Dermal fibroblasts 
from seven patients with hereditary resistance to calcitriol (mutant fibro- 
blasts) had VDR functional defects characterized previously  (6, 19, 39, 40, 
59, 74). 
Other cells and their sources were as follows: CV-I monkey fibroblasts, 
CL9 rat liver cells, and LLC-PK1 porcine kidney epithelial cells (Ameri- 
can Type Culture Collection, Rockville, MD); MCF-7 human breast cancer 
cells (Dr. Marc Lippman, Georgetown University, Washington,  DC); ROS 
17/2.8 rat osteosarcoma cells (Dr. Gideon Rodan, Merck Sharp & Dohme, 
West Point,  PA); and UMR-106 rat osteosarcorna  cells (Dr. N. Partridge, 
Washington University,  St.  Louis, MO). 
Cell Culture and Incubation with Steroids 
Cells were grown in Dulbecco's minimal essential medium (from Biofluids, 
Reckville,  MD) supplemented with 0.2 mM glutamine, 80 rag/liter gen- 
tamycin (both from Gibco Laboratories, Grand Island, NY), and with 0.1 
#M insulin (regular lletin I, beef-pork; Eli Lilly & Co., Indianapolis, IN), 
and with 10% defined fetal bovine serum (from HyClone Laboratories, Lo- 
gan, UT). Cells were maintained in 150-era  2 plastic tissue culture flasks 
(Costar, Cambridge, MA) at 37"C in an atmosphere of 5% CO2/95% air. 
Cells  from  passages  12-25  were  used.  All  cell  lines  were  tested  for 
mycoplasma (American Type Culture Collection) with negative results. FOr 
all experiments,  cells were subcultured (10,000 per well) into two-chamber 
tissue eniture glass slides (Lab-TeL Naperville, IL), precoated with human 
fibronectin (10 t~g/well; Collaborative Research Inc., Bedford, MA). Cells 
were used for experiments at 70 % confluency. 
For certain experiments, the monolayers were preincubated for 2-8 d be- 
fore the experiments in phenol red-free (11) and serum-free medium (Cribco 
Laboratories) supplemented by 1% ITS-Premix additive (Collaborative Re- 
search Inc.). Such cells express a normal effect of 1,25-(OH)2D3 on DNA 
synthesis or on 250HD3 24-hydroxylase  activity (6). FOr one subgroup of 
these experiments, the cells were exposed for 30 rain to WGA (2 mg/ml with 
detergent [5 #g/ml; Alconox Inc., New York]) in Eagle's minimal essential 
medium without phenol red (Gibeo Laboratories), with 0.3 g/liter bovine 
serum albumin (Bcehringer Mannheim Biochemieals, Indianapolis, IN), 
0.5 mM calcium, 0.5 mM magnesium, 25 mM Hepes, pH 7.4 (medium A). 
Pilot studies  (not shown)  with fluorescein isothiocyanate-labeled WGA 
(Vector Laboratories, Inc.) indicated that with these conditions WGA aceu- 
mnlated in a perinuelear distribution and along the nuclear envelope. 
For analysis of rapid regulation of VDRs,  we added steroid analogues 
to cells in medium A. We dissolved the analogues in ethanol, and final etha- 
nol concentration  in control and in hormone-supplemented  media was 0.1%. 
We found that 0.1% ethanol did not influence VDR compartmentalization 
but much higher concentrations (10-70%) did (data not shown). 
Cell l~xation 
After brief incubation with a steroid,  cell monolayers  were fixed immedi- 
ately with brief microwave irradiation as recently described in detail (5). 
We used a commercial microwave oven (model No. RCS 700; 650 watt max- 
imum output, 2.45 GHerz; Amana Refrigeration  Inc., Amana, IA), with 
a continuous mode, making brief energy exposure possible. We fixed only 
a single slide at a time, without presence of an added water load in the oven. 
This was possible because of a built-in ceramic shelf and magnetron protec- 
tion in this mode (50).  Uniformity of heating was further improved by a 
model stirrer. Before placing cells in the oven, we turned on the power for 
1 rain. Cell monolayers with a small covering layer of medium (total volume 
of cells plus medium was 200 ~l/chamber) were exposed for 9-15 s to maxi- 
mal power. Final temperature of the cells monitored with a needle micro- 
probe thermometer (Sensortek,  Clifton, NJ) was 50 +  6oc. Optima/slide 
position in the oven and optimal fixation time were established by monitor- 
ing homogeneity of temperature changes on a chamber slide covered with 
a temperature indicator (Omegalaq;  Omega Engineering Inc., Stamford, 
CT), integrity of cell structure by light microscopy after conventional stain- 
ing, and signal to background ratio by immunocytology.  Fixation for shorter 
time prevented development of specific VDR immunoreactivity due to poor 
antibody accessibility,  while excessive microwave exposure caused struc- 
tural damage to cells. Optimal fixation time was 10 s for fibroblasts, 9 s for 
MCF7 cells,  12 s for ROS 17/2.8 cells,  and 15 s for LLC-PKI cells.  De- 
hydration was minimized by use of a lid to cover each slide chamber. Im- 
mediately after microwave exposure,  1 tnl PBS was added to each chamber. 
For comparison, some samples were fixed with five different  conven- 
tional  methods:  cryofixation  (12),  3.5%  fresh  paraformaldehyde  (48), 
methanol-acetone at  -20°C  (10),  ethanol-based fixative  (Cytoprep per 
manufacturer's  instructions; Fisher Scientific Co., Silver Spring,  MD), or 
microwave fixation of specimen in aldehyde  solution (43). 
lmmunostaining 
The upper chamber of the slide unit was removed,  and cell monotayers on 
the lower glass slide were incubated 15 rain each with avidin solution and 
then with biotin solution (Blocking Kit; Vector Laboratories, Inc.) and then 
for 30 rain with blocking serum (normal serum [5 % in PBS] from species 
of second antibody). Primary anti-VDR antibody (9A7 at 1:1,000 dilution, 
VD2F12  at 1:2,000 dilution, or IVG8Cll at 1:1,500 dilution) was diluted 
in 4% human serum and then incubated with specimens for 1 h. 
Affinity-purified biotinylated second antibody was selected for each pri- 
mary antibody to give the highest signal-to-noise ratio.  The 9A7 primary 
antibody was characterized for binding to a panel of potential second anti- 
bodies. For 9A7 we selected either the anti-mouse IgG from Vector Labora- 
tories, Inc.  (this has high cross-reaction with rat IgG) or the anti-rat IgG 
from Zymed, the anti-mouse IgG gave the best signal-to-background ratio 
with 9A7 primary antibody.  For VD2FI2 and for IVGSCll we used anti- 
mouse IgG from Vector Laboratories, Inc.  or anti-monse IgG from Ac- 
curate Chemical & Scientific  Corp.  (Westbury,  NY). 
Biotinylated second antibodies were diluted according to manufacturer's 
recommendation and were applied for 30 min, followed  by addition of 
avidin/biotinylated phycoerythrin (Vector Laboratories, Inc.) for 30 rain. 
Each incubation step was followed by three 5-rain rinses with PBS. After 
the  final  rinse cells were  mounted  in aqua-polymount medium  (Poly- 
sciences, Inc., Warrington, PA). All staining procedures were at room tem- 
perature in a humidified box, shielded from light, and continuously tilted. 
Every cell line with each experimental condition was analyzed at least three 
times. Additional experiments were done with conventional stains to evalu- 
ate  related  cell  structures;  we  used  azure  H  (0.05%/methylene blue 
(0.02%)/sodium borate or methyl green or acridine orange stains (72). 
Photomicroscopy and Image Processing 
We  analyzed  slides  with  a  Zeiss  Photomicroscope  HI  equipped  for 
epifluorescence  analysis.  Phycoerythrin gives a signal with epifluorescent 
illumination with or without an associated phase-contrast image.  Images 
were photographed directly from the microscope with a built-in camera; al- 
ternatively,  images  were  captured  with video  cameras,  digitized,  then 
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by lmmunocytology with 9A 7 Antibody and by Calcitriol 
High A~inity Binding Capacity  from Competitive Binding 
Studies with [zH]Calcitriol in Various Cell Lines 
VDR amount by 
calcitriol high 
affinity binding  VDR amount by 
Cells  capacity*  immunocytology 
MCF-7 
ROS 17/2.8 
UMR-106 
Human fibroblasts 
(normals) 
LLC-PK1 
CL9 
CV1 
Mutant fibroblasts 
(patient No.  11  with 
calcitriol-binding 
defect of VDRs) 
sites/ceU 
15,000-18,~0  +  +  +  +  +  + 
15,000-18,000  +  +  +  +  +  + 
14,000  +++++ 
3,000-10,000  + + + 
5,000-7,000  + + + 
<800  + 
<500  Very low 
Undetectable  Very low 
* Calcitriol binding capacities  from  prior publications; references  available  by 
request to J. Barsony. 
processed and analyzed  with computer assistance, and then photographed 
from  the computer  screen. Paired control and experimental fluorescent  im- 
ages were photographed with the shutter opened for the same duration, or 
with camera  controller set for the same  gain and offset. Fluorescent images 
were captured with a Dage/MTI  CCD-72 Solid State Camera  equipped with 
an Opelco intensifier KS3-CD. Color images were captured with a Sony 
XC-O07 precision Tricolor Camera. Images  were processed and analyzed 
using a system  from  G. W. Hannaway  and Associates  (Boulder, CO). Recep- 
tor immunoreactivity  was expressed  as fluorescent  intensity  or color signal 
and analyzed  by computer  for intensity, size, and distribution of  that signal. 
Each type  of  analysis  was internally  consistent  with regard  to immunocytol- 
ogy method, magnification, and instrument settings. Variability is ex- 
pressed as mean and 1 SD. 
Results 
Validation of  lmmunocytology Method 
Immunocytology  of VDRs using microwave fixation, the 9A7 
primary antibody, and the immunostaining system based on 
the phycoerythrin fluorophore produced an intense and rela- 
tively  uniform  signal  over  large  areas  of the  slide  (not 
shown). Cell morphology was at least as good as from that 
after fixation with other conventional methods except that 
after microwave fixation there were occasional burning ar- 
tefacts evidenced by structural damage (vacuolization or re- 
ticular pattern in cytoplasm, or disruption of plasma mem- 
brane or nuclear membrane) in small regions close to the 
edges of the slides. 
We found variability in the amount of VDR per cell within 
each  sample; a  similar variability has been reported with 
other steroid receptors after conventional fixation (62). Stain- 
ing  heterogeneity  may reflect differences in  physiological 
state among members of the cell population (such as asyn- 
chrony in the cell cycle). 
Since we found strong signals from and novel distributions 
of VDR (see below), we did detailed analyses to rule out the 
possibility that much of the signal might be nonspecific. (a) 
With anti-VDR antibody omitted or replaced with a nonim- 
mune rat ascites fluid, we did not detect a phycoerythrin sig- 
nal (not shown).  Similar controls have been used with 9A7 
antibody  and  aldehyde  fixatives (9,  12,  15,  48).  (b)  The 
amount of VDR by immunocytology in different cell lines 
correlated with the amount of receptor predicted from bio- 
chemical studies, including virtual absence of VDR signal 
in CV1 cells and in one mutant cell line with undetectable 
high affinity binding of calcitriol (Table I). (c) when 9A7 pri- 
mary antibody was replaced by either of two different pri- 
mary antibodies against VDRs and with appropriate second 
antibody,  we  found the  same amount  and  distribution  of 
VDRs as with the 9A7 anti-VDR antibody (not shown). 
Slow Effect of  Serum or Estrogen on Intranuclear 
Accumulation of Vitamin D Receptors 
When normal human fibroblasts were cultured with medium 
containing serum and phenol red (final concentration of cal- 
citriol was 0.53  pg/ml, total estrogen was 9.5  pg/mi; both 
analyzed by Nichols Institute  Lab.,  San Juan  Capistrano, 
CA), at least 50% of VDRs were in the nucleus (Fig.  1 a). 
Less than 5 % of VDRs in the nucleus and in the cytoplasm 
were in the form of clumps (defined as VDR signal area >10 
pixels), and VDRs showed no alignment along fibrils before 
calcitriol addition. 
When we cultured fibroblasts without serum and phenol 
red for 48 h, the VDRs were dispersed as fine granules prin- 
cipally in the thick perinuclear zone of the cytoplasm with 
fewer VDRs inside the nucleus (Fig. 1 B). We saw no associ- 
ation  of VDRs  with  plasma membrane or  nuclear  mem- 
brane. Longer periods of culture without serum and phenol 
red caused VDRs to become exclusively cytoplasmic; VDRs 
were much more peripherally distributed in the cytoplasm 
after 7 d than after 2 d of culture in this medium (Fig.  1 C). 
We  cultured  cells  without  serum  and  phenol  red  after 
48 h and then added back serum for 24 h; VDRs were then 
predominantly intranuclear. If  we added for 24 h only phenol 
red  (11) or graded doses of a  series of analogues of 17~- 
estradiol, we noted effects similar to those from serum. This 
slow effect of a steroid on VDR distribution showed the ana- 
logue specificity of an action mediated by the estrogen recep- 
tor. Similar effects were induced by 17~estradiol at 10  -9 M 
and higher and by 17ceestradiol or diethylstilbestrol at 10  -7 
M and higher; androstenediol or progesterone were ineffec- 
tive at concentrations up to 10  -~ M. We also evaluated the 
time course of this process. After culturing fibroblasts 48 h 
without serum or phenol red, we added  17~estradiol (10 -7 
M) for varying times (including 0.5, 3,  12, and 18 h and at 
1-d increments up to 8 d). VDR intranuelear accumulation 
became detectable after 18 h and was maximal (80%) after 
5 d. We termed these effects of estrogen or serum "slow" to 
contrast them with the more rapid effects of calcitriol (see 
below). 
Rapid Effects of Calcitriol on Vitamin D Receptor 
Organization and Compartmentalization 
Cells cultured for 48 h without serum and phenol red were 
treated briefly with calcitriol (10  -s M) to study rapid time- 
dependent changes of VDR organization and compartmen- 
talization. Within 15 s (the earliest time point evaluated) af- 
ter calcitriol addition,  the VDR pattern changed.  Analysis 
Barsony et al. Rapid  or Slow  Regulation of Vitamin D Receptors  2387 Figure 1.  Subcellular localization of VDRs in normal human dermal fibroblasts (,4) cultured with serum and phenol red, (B) cultured 
without serum and phenol red for the final 2 d, or (C) cultured without serum and phenol red for the final 7 d. Fluorescence images. 
Bar, 10 pro. 
of 100 cells showed that before calcitriol addition 8.5 +  3 % 
of VDR  immunoreactivity was  accounted for by  clumps 
(defined as signal area >10 pixels); by 15 s after calcitriol the 
percent of VDRs in clumps was 26 +  11 (P < 0.001). Larger 
clumps (VDR signal area >20 pixels) were a smaller frac- 
tion; at 0, 15, and 45 s the fractions of  VDRs in larger clumps 
were 0, 3  +  1, and 16 +  4 (P <  0.001 for all comparisons) 
(Fig. 2; Fig. 3 A vs.  Fig. 3 B). 
By 30 s after calcitriol addition ,,040% of all VDRs ap- 
peared  in  clumps;  by  this  time the clumps  were  mainly 
aligned along fibrils, radiating from the nucleus to the pe- 
riphery (Fig. 3 B). By 45 s, the VDR clumps were distrib- 
uted closer to the nucleus. By 1 min, the clumps were mostly 
along the nuclear envelope, and some of them were already 
inside the nucleus and nucleoli (Fig. 3 C). By 3 min most 
of the VDRs were within the nucleus with a small proportion 
still detectable near the nuclear membrane; about 30% of all 
VDRs  remained  dispersed  in the cytoplasm (Fig.  3  D). 
Thereafter, the pattern of VDRs was essentially unchanged 
during 3-30 min of exposure to calcitriol. We observed the 
same calcitriol-induced changes in VDR patterns with any 
of the three monoclonal antibodies against VDRs. 
About 30% of the total cell population seemed to react to 
calcitriol more slowly, being at various stages of  this process 
between 3 and 30 rain after hormone addition. 
Lower calcitriol doses caused similar stepwise reorganiza- 
tion of VDRs with threshold dose of 10  -H M, but the reor- 
ganization was slower with lower doses (i.e., VDR clumping 
started after 1 rain at 10  -11  M but after 30 s with 10  -9 M 
calcitriol).  Incubation for 0.25-10  min with  17/5-estradiol 
(10  -7 M), dexamethasone (10  -7 M), retinoic acid (10  -7 M), 
1/3-dihydroxycholecalciferol  (10  -8  M),  and  cholecalciferol 
(10  -7 M) did not change VDR organization or localization. 
When fibroblasts were cultured with serum and phenol 
red, calcitriol (10  -7 M) also caused rapid changes in VDR 
organization. VDRs in cytoplasm and nucleus were mainly 
dispersed before calcitriol addition (Fig. 4 A). During the 
brief incubation with caicitriol, nuclear clumping of VDRs 
occurred immediately  in 20% of  all cells (at 15 s: the earliest 
time point evaluated),  quickly involving 40%  of all cells 
(within 30 s). Many VDRs aligned along intranuclear fibrils 
(beginning at 30 s) and then accumulated in the nucleoli (Fig. 
4 C) and close to the nuclear membrane (beginning at 60 s 
and reaching maximal level by 3 rain). Simultaneously  a por- 
tion of cytoplasmic VDRs became aligned along fibrils (Fig. 
4  B).  Intranuclear translocation of VDRs  was  detectable 
though usually subtle. Computerized analysis of single cells 
in one experiment showed a ratio of average nuclear/average 
whole cell VDR fluorescence in 30 cells before and after cal- 
citriol of 1.08 +  0.13 vs. 2.1  +  1.0 (P <  0.001). Both cyto- 
plasmic and nuclear reorganization of VDRs were complete 
within 3 rain, involving 60-70 % of all the VDRs. Calcitriol 
caused identical time-dependent reorganiTation of VDRs in 
MCF-7 breast cancer cells, in LLC-PK1 kidney epithelial 
Figure 2. Rapid clumping of VDRs after calcitriol (10  -s M) addition. Fibroblasts were cultured for final 2 d without serum or phenol red. 
(A) Control fibroblasts without calcitriol; (B) fibroblasts with calcitriol for 30 s. Fluorescence images. Bar, 10 ~m. 
The Journal  of Cell Biology,  Volume 111, 1990  2388 Figure 3. Time course of rapid effects of calcitriol  (10  -s M) on VDR organization and compartmentalization  in fibroblasts. Fibroblasts 
were cultured without serum and phenol red for 2 d: (A) no added calcitriol,  (B) with calcitriol for 30 s (clumping of VDRs and alignment 
of  VDR clumps along fibrils, directed radially towards the nucleus), (C) with calcitriol for 1 rain (perinuclear and intranuclear accumulation 
of clumped VDRs), (D) with calcitriol for 3 rnin (VDR accumulation within nucleus and nucleolus). Each panel shows VDR fluorescence 
combined with simultaneous  phase-contrast  image. Bar,  10 #m. 
cells, in ROS 17/2.8 osteosarcoma cells, CL9 rat liver cells, 
and in normal human dermal fibroblasts. 
When we fixed fibroblasts with any of five standard fixa- 
tion protocols, (see Materials and Methods) the sensitivity 
of VDR staining was lower, almost all detectable VDRs were 
inside the nucleus,  and no VDR reorganization after brief 
calcitriol addition or chronic estrogen addition could be de- 
tected. 
Rapid Effects of  Calcitriol in Fibroblasts Pretreated 
with Wheat Germ Agglutinin (WGA) 
We added  WGA because of its potential to block protein 
transport through nuclear pores (51, 77). These studies were 
done with cells cultured for 48 h without serum and phenol 
red. 
WGA preincubation did not have an effect on VDR distri- 
Figure 4. Time course of rapid effects of calcitriol (10  -7 M) on VDR organization in fibroblasts. Fibroblasts were grown only in complete 
medium, which included serum and phenol red, and then tested: (A) no added calcitriol,  (B) calcitriol added for 30 s (VDRs in cytoplasm 
and nucleus have become clumped), (C) calcitriol added for 3 rain (clumped VDRs have accumulated in nucleolus). Fluorescence images. 
Bar, 10 gm. 
Barsony et al. Rapid or Slow Regulation of Vitarqin D Receptors  2389 Figure 5. Effect of brief preincubation with WGA on the subsequent  rapid change of VDR compartmentalization after calcitriol (10  -8 M) 
for 5 rain) addition.  (A) Control cells with calcitriol but without WGA preincubation (most VDRs are inside the nucleus,  compare with 
Fig. 2 A); (B) cells preincubated  for 30 min with WGA before calcitriol addition  (most VDRs are outside the nuclear envelope).  Fluores- 
cence images.  Bar,  10 ~tm. 
bution  in  unstimulated  cells,  nor  did  it  influence  VDR 
clumping and alignment after calcitriol addition.  However, 
WGA prevented  intranuclear  accumulation  of VDR  3-30 
min after addition of calcitriol and stabilized a greater than 
normal perinuclear accumulation of VDRs (Fig.  5). 
Rapid Effects of Calcitriol in l~broblasts from Patients 
with Defective Vitamin D Receptor Function 
We analyzed cells from seven patients with defects of VDR 
function (mutant cells) (Table II). We tested the mutant cells 
after 48 hours culture without serum and phenol red. 
VDR-binding to calcitriol was undetectable in cells from 
three patients (No. 8, No.  10, and No.  11). Two mutant cell 
lines  (No.  8  and  No.  10)  showed variably  decreased  im- 
munoreactivity with different anti-VDR antibodies,  and the 
signal was undetectable in a variable number of cells.  Most 
importantly, no reorganization of the signal was seen in cells 
exposed to calcitriol. 
In the other of these three (No. 11) the amount of VDR was 
<10% of normal (Table I) (compare Fig. 3 A with Fig. 6 A) 
with all three primary antibodies.  After addition of 10  -7 M 
calcitriol, we observed a rapid clumping, alignment, and in- 
tranuclear accumulation of VDRs. Although the number of 
VDR  dumps  was  strikingly  decreased,  the  entire  time 
course of VDR reorganization was normal  (Fig.  6, A-C). 
The  particularly  low  amount  of refractory  VDR  in  cyto- 
plasm of this cell line beyond 1 min after calcitriol addition 
suggested that much of the refractory cytoplasmic signal in 
the normal cell lines was specific for VDR. 
In two mutant cell lines (No.  la and No. 2a) with normal 
VDR  binding  to  calcitriol  and  normal  VDR  binding  to 
nonspecific DNA but with defective calcitriol uptake into the 
nucleus the amount of VDR by immunocytology was nor- 
mal.  Within  30  s  after  calcitriol  addition,  VDRs became 
clumped;  then  these  clumps aligned along cytoplasmic fi- 
brillar elements with abnormal, whorl-like orientations (Fig. 
7).  After 1 rain with calcitriol almost all VDRs were close 
to the nucleus.  We could not detect intranuclear accumula- 
tion of VDRs between  1 and 30 min. 
In two mutant cell lines (No. 3 and No. 7) with decreased 
VDR binding to DNA, the distribution of VDRs in unstimu- 
Table II. Relations Between Hereditary Defects in Vitamin D Receptor (VDR) Function and Rapid Changes of 
Organization and Compartmentalization of VDR After Calcitriol (10  -8 M) 
Source of fibroblasts*  Biochemical classification of VDR function*  Calcitriol-induced rapid change in VDR organization  arid compartmentalization 
Normals (n  =  3)  Normal  Initially dispersed in cytoplasm, then rapid clumping, then radial 
Patient  11 
Patients 8  and  10 
Patients  la and 2a 
Patients 3 and 7 
VDR calcitriol-binding defect 
VDR calcitriol-binding defect 
Defective uptake of calcitriol into the nucleus 
VDR DNA-binding defect 
alignment along fibrils, then perinuclear  accumulation, then 
accumulation in nucleus (especially in nucleoli) 
Very low amount of VDR; all VDR changes normal after calcitriol 
Variable amount of VDR; no VDR changes after calcitriol 
Clumping, abnormal whorl-like alignment,  exaggerated perinuclear 
accumulation; no intranuclear accumulation of clumped VDRs 
Normal cytoplasmic clumping,  alignment, and perinuclear 
accumulation; no intranuclear accumulation or clumping of VDRs 
* The VDR functional categories were established in prior reports (6, 19, 39, 40, 59, 74). Patients and their cells are assigned the same identification symbols 
as in those reports. Cells from patients No. 3 and No. 7 have an identical homozygous  point mutation in the VDR DNA-binding  zinc finger domain, although 
the two patients are not known  to have  common  ancestors (69). Cells from  patient No. 8 have  a homozygous  point  mutation  causing  early  termination to transcrip- 
tion of the VDR mRNA  (Pike, J. W., unpublished data). This mutation is identical to a recently reported mutation in several members of an extended kindred 
(63) though no common  ancestry is known  between patient No. 8 and the other kindred. 
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on VDR distribution in dermal fibroblasts 
from a patient with an hereditary defect in 
VDR  binding to  calcitriol (mutant  fibro- 
blasts; No.  11): (A) no calcitriol added to 
cells (very low numbers of  dispersed  VDRs); 
(B) 30 s after calcitriol  added to cells (VDRs 
clumped, but fewer VDR clumps than nor- 
real); (C)  3  rain after calcitriol added to 
cells (clumped VDRs in nucleoli, but fewer 
clumps than normal). All panels show si- 
multaneous  VDR  fluorescence  combined 
with phase-contrast image. Bar,  10 ~m. 
Barsony et aL Rapid or Slow Regulation of Vitamin D Receptors  2391 Figure 7. Rapid calcitriol (10-SM) effect  on VDR distribution in mutant fibroblasts from patient No. 2a with hereditary defect in calcitriol 
uptake into the nucleus. Mutant ceils (A) without calcitriol (VDRs in normal pattern), (B) after 30 s with calcitriol added (abnormal whorl- 
like orientation of  aligned VDR clumps in cytoplasm), (C) after 3 rain with calcitriol added (clumped  VDRs near nucleus with circumferen- 
tial alignment; VDR clumps fail to accumulate inside nucleus). All panels show simultaneous VDR fluorescence combined with phase- 
contrast image. Bar, 10/~m. 
lated cells was normal. After addition of calcitriol, there was 
apparently normal clumping and alignment of VDRs within 
1 min, but there was no reorganization of intranuclear VDRs 
and no accumulation of  VDRs in the nucleus for up to 30 min 
(Fig. 8). 
Discussion 
We selected microwave fixation  because it could have advan- 
tages over other fixation  methods (5, 37, 42). First, the rapid- 
ity of fixation allows excellent time resolution (5, 50). Al- 
though rapid freezing can also give excellent time resolution, 
this generally requires subsequent specimen incubation in a 
fixative solution (71), and the fixation step may change reten- 
tion, organization, or compartmentalization of many pro- 
teins.  Second,  microwave fixation with or without added 
chemical fixatives can preserve antigenic epitopes as well as 
or even better than other methods (5, 30, 32, 38). Third, anti- 
bodies efficiently can reach intracellular sites in intact cells 
after microwave fixation without further permeabilization 
steps (5).  Permeabilization steps,  such as with detergents, 
can change compartmentalization and even remove some 
proteins. 
We considered whether some of our findings might be, in 
part, an artifact of microwave fixation. But since microwave 
fixation does not cause reorganization of most cellular pro- 
reins  (5, 32, 38; Barsony, J., unpublished data), the VDRs 
would have to acquire a unique lability to microwave irradia- 
tion after brief exposure to calcitriol. We believe it more 
likely that our findings including the rapid VDR subcellular 
reorganization after calcitriol exposure are valid and may be 
morphologic counterparts to changes suggested in biochemi- 
cal analyses with VDRs (13, 28,  60). 
We established the specificity of the VDR signal in this 
study with multiple standard criteria (see Results).  Three 
types of experimental result supported further the specificity 
of our VDR signal: (a) the calcitfiol dose and analogue de- 
pendency of VDR reorganization, (b) the extreme rapidity 
of the VDR reorganization after calcitriol, and (c) the types 
of disruptions of VDR cytologic patterns associated with 
hereditary defects in VDRs. 
Approximately 30%  of the VDR signal was refractory to 
reorganization after calcitriol addition in normal cells, and 
all of the signal was refractory in two mutant cell lines (No. 
8 and No.  10).  (VDR protein was undetectable by two-site 
immunoradiometric  assay in fibroblasts from patients No. 10 
and No.  11 [see reference 66; DeLuca, H. F., unpublished 
data] and undetectable by immunoblot assay in fibroblasts 
from patient No.  8  [see  reference 58; Pike, J. W., unpub- 
lished data].) The refractory signal was randomly distrib- 
uted in the cytoplasm and nucleus. This refractory signal 
may be from proteins other than VDRs and/or from ineom- 
Figure 8. Maximal effect of calcitriol (10  -s M for 3 min) on VDR distribution in mutant fibroblasts from patient No. 7 with hereditary 
defect in VDR binding to DNA (VDRs are clumped in cytoplasm, but clumped VDRs are not present in the nucleus). (A) Fluorescence 
image; (B) Simultaneous VDR fluorescence combined with phase-contrast image. Bar, 10 gin. 
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VDRs (49).  The three monoclonal primary antibodies are 
likely to react principally with differing epitopes on the VDR, 
and each may cross-react with other proteins. 9A7, the prin- 
cipal anti-VDR antibody that we used, is a monoclonal IgG 
recognizing one VDR epitope common to birds and mam- 
mals (45, 59). We do not presently know if the 9A7 antibody 
shares a portion of the epitope recognized by the VD2F12 
antibody (11-20%  overlap between 9A7 and VD2F12 anti- 
bodies in an assay based on competition of antibodies for 
partially purified VDRs) (Barsony,  J., and R. E  Schurnan, 
unpublished data [Antibody Resources Inc., Rockville, MD]). 
However,  the VD2F12 and the IVG8Cll monoclonal anti- 
bodies bind to two distinct VDR epitopes (16, 56). 
We found with microwave fixation that a variable fraction 
of VDRs was cytoplasmic. When cells were cultured without 
serum and phenol red, most VDRs were dispersed in the 
cytoplasm. But even with culture in standard media and brief 
addition of calcitriol,  we  still  found some VDRs  in  the 
cytoplasm. Differences in cell culture, fixation methods, and 
detection methods account for our differences from previous 
reports,  in which immunocytology with 9A7 antibody de- 
tected VDRs only inside the nucleus (8, 12, 15, 48). And we 
verified that the VDR distributions with these prior methods 
were different than with our method. A feature common to 
all of those prior cytologic studies was slow fixation in alde- 
hyde-based solutions. We suggest that rapid interactions of 
aldehydes or other fixatives with a mobile receptor protein 
or other cellular components could largely account for the 
dependency of  VDR compartmentalization  on fixation meth- 
od. Furthermore, prior studies of VDRs used detergents or 
other solutions that could have selectively depleted VDRs 
from the cytoplasm (75). 
We studied VDR subcellular compartmentalization and 
organization and recognized a slow regulation by estrogen 
and a rapid regulation by calcitriol. After long-term culture 
without serum and without phenol red, the subsequent addi- 
tion of serum or an estrogen was sufficient  to induce predom- 
inant intranuclear localization of VDRs. Culture components 
such as serum and phenol red can influence immunocyto- 
chemical localization of the glueocorticoid receptor (54); 
slow effects of estrogen on the compartmentalization of the 
estrogen receptor are controversial (53, 55). Phenol red prep- 
arations are mixtures that include estrogenic agonists (11), 
and we found estrogen analogue specificity of the slow effect 
of phenol red preparations or steroids on VDRs, suggesting 
mediation through estrogen receptors. The long time lag (18 
h) necessary for development of the estrogen effect on VDR 
redistribution between cytoplasm and nucleus suggests that 
it involves new protein synthesis. 
Since there were traces of  estrogen and calcitriol in the se- 
rum we used, either or both might contribute to slow redis- 
tribution of VDRs caused by serum. There may be serum 
components other than estrogen, which can induce this slow 
effect.  The slow effects of estrogen and/or serum may be 
physiologically important and warrant further studies. 
In the intact organism estrogen, ealcitriol, or other modu- 
lators may indirectly cause 70% or more of VDRs to reside 
within the nucleus, but the extranuclear portion of receptors 
could also have important functions. For example, physio- 
logic evidence for VDR-mediated rapid calcitriol actions at 
the plasma membrane or in cytoplasm (14,  18, 41, 67) sug- 
gests that some extranuclear VDRs are functional. 
Unlike the slow effect of  estrogen or serum on VDR distri- 
bution, the calcitriol effects on VDRs were rapid. It was eas- 
ier to visualize this rapid VDR reorganization in cells cul- 
tured without serum and phenol red.  However, we found 
similar rapid calcitriol-induced VDR reorganization steps in 
the cytoplasm and nucleus also with fibroblasts cultured with 
serum and phenol red. 
The earliest VDR change we observed after calcitriol ad- 
dition was clumping of VDRs.  This could be an anatomic 
counterpart for the steroid receptor homodimerization pro- 
cess (36).  The next rapid step we observed was alignment 
of VDR clumps along cytoplasmic fibrils, directed radially 
toward the nucleus. Receptor clumps moved closer to the nu- 
cleus at 30-45 s than at 15 s after calcitriol. Cytoskeleton 
elements may be involved in the activation process of other 
steroid receptors (65). 
After 1 rain with calcitriol, clumped VDRs were prin- 
cipally around the nuclear envelope. This pattern suggested 
that reorganizing VDRs do not move unimpeded across the 
nuclear envelope. The rapid, calcitriol-dependent transloca- 
tion of VDRs into the nucleus could be disrupted by WGA. 
WGA binds to nuclear pore proteins and thereby can stop the 
translocation of many large molecules, which would nor- 
maUy be actively transported through those pores (51, 77). 
Accentuated perinuclear accumulation and lack of intranu- 
clear accumulation of VDRs after ealcitriol was seen after 
WGA pretreatment and also in two mutant cell lines, suggest- 
ing disruption at similar steps. 
Calcitriol caused within 1-5  min not only intranuclear 
VDR  accumulation but  also  a  reorganization of the  in- 
tranuclear VDR pattern. Calcitriol caused VDRs to accumu- 
late preferentially in the nucleoli, as well as in other in- 
tranuclear aggregates and close to the  nuclear envelope. 
These distribution patterns were similar to those reported for 
at least two other proteins that could interact with VDRs: es- 
trogen receptors (22, 62) and the 70-kD heat shock protein 
(47), which has been reported to form complexes with recep- 
tors for one or more steroid hormones (35).  Some fibrillar 
elements were visible in the nucleus also, with VDR clumps 
aligned along them. This rapid rearrangement of VDRs in 
the nucleus may be an extension of previous biochemical 
studies showing interaction of steroid receptors with the nu- 
cleus (2, 3). 
One class of mutant cells may have a defect in these in- 
tranuclear steps as there was lack of intranuclear accumula- 
tion and of intranuclear reorganization but no accentuated 
perinuclear accumulation of VDRs. This was caused by a 
homozygous point mutation near the base of the second zinc 
finger (69) in a region without recognized nuclear localiza- 
tion signal. A prior study also implicated the zinc finger re- 
gion as contributing to the nuclear localization process for 
the progesterone receptor (26).  Our study illustrates that 
mutagenesis will be suitable to define further the VDR do- 
mains determining, components of the reorganization pro- 
cesses that we have imaged. 
We conclude that immunocytology with microwave fixa- 
tion is suitable for tho-.study of VDR organization and its 
regulation by steroids and possibly other factors. The reor- 
ganization and, in particular, the cytoplasm-to-nucleus trans- 
location of VDRs after calcitriol were more rapid than the 
translocation suggested by most prior studies of steroid-re- 
lated receptors (55, 73). The rapidity of the changes after 
calcitriol is sufficient for these changes to be involved in 
Barsony et al. Rapid or Slow Regulation of Vitamin  D Receptors  2393 one or more physiologic processes. These simultaneous pro- 
cesses include rapid nongenomic effects of calcitriol, cal- 
citriol transport into the nucleus, VDR maturation or recy- 
cling, and VDR activation for transcriptional competence. 
We are grateful to Ms. Wilma McKoy for skillful assistance in cell culture 
and to Dr. Yosi Weisman for cells from patient No.  8. 
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